Eat Well Produce Benefit for Diabetes and Food Insecurity
An Evaluation of Eat Well, a Produce Benefit, for Patients With Diabetes and At-risk for Food Insecurity
1 other identifier
interventional
2,177
1 country
1
Brief Summary
The goal of this clinical trial is to assess the impact of participation in Eat Well for diabetes patients who are at risk of food insecurity. The main questions it aims to answer are:
- whether there is a difference in Haemoglobin (Hb) A1c measurements and emergency department (ED) utilization between the Eat Well and control groups up to 18 months post-program completion.
- whether there are differences in cardiometabolic health-related outcomes for Eat Well participants. Participants in the program will receive gift/debit cards for fruits and vegetables and educational nutrition materials. Researchers will compare Eat Well participants with those only receiving educational materials to see if there are differences in cardiometabolic health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Jun 2023
Typical duration for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2023
CompletedFirst Posted
Study publicly available on registry
June 9, 2023
CompletedStudy Start
First participant enrolled
June 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMay 8, 2026
May 1, 2026
1.1 years
May 26, 2023
May 6, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in HbA1C
A measure of average blood sugar levels over the past 3 months.
18 months pre program, during program enrollment, up to 12 months
Change in number of ED Visits
Number of ED visits throughout the study period
up to 18 months pre program, during program enrollment, up to 12 months
Secondary Outcomes (10)
Outpatient visits
up to 18 months pre program, during program, and up to 18 months post program
Hospitalizations
up to 18 months pre program, during program, and up to 18 months post program
Change in weight
up to 18 months pre program, during program, and up to 18 months post program enrollment
Change in body mass index (BMI)
up to 18 months pre program, during program, and up to 18 months post program
Change in cholesterol
up to 18 months pre program, during program, and up to 18 months post program
- +5 more secondary outcomes
Study Arms (2)
Eat Well
EXPERIMENTALThe experimental group will participate in the Eat Well Produce Prescription program, receiving an $80 monthly benefit for eligible produce for 12 months and diabetes education materials through email, including curated nutrition and diet information from the Diabetes Resource Page, consistent with standard of care at Duke University Health System.
Control
NO INTERVENTIONThe control group will receive usual care (including diabetes educational materials) without the prescription benefit.
Interventions
A program offered by Reinvestment Partners giving clients gift/debit cards that allow the purchase of WIC approved fruits and vegetables.
Eligibility Criteria
You may qualify if:
- Be active in the Duke Diabetes Registry in the past 12 months AND
- have had at least one outpatient A1c measurement AND
- are at risk for food insecurity as defined by one of the following:
- answered often true or sometimes true on one or both of the food insecurity questions as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
- answered hard or very hard to the financial stress question as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
- has Medicaid as insurance payer OR
- lives in Area Deprivation Index (ADI) zip code of 7th decile or harder
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27708, United States
Related Publications (3)
Rader A, Buckman C, Pignone M, German JC, Spratt SE, McPeek Hinz E, Brucker A, Hoeffler S, Kane RM, Drake C. Factors Associated with Produce Prescription Program Enrollment and Benefit Use Among Patients with Diabetes and At Risk for Food Insecurity. J Nutr. 2026 Apr 24:101548. doi: 10.1016/j.tjnut.2026.101548. Online ahead of print.
PMID: 42036037DERIVEDDrake C, Buckman C, Brucker A, McPeek Hinz E, Pignone M, Shaikha H, Rader A, Granados I, Goldstein BA, Chamorro C, Hoeffler S, Wirth C, Spratt SE. Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial. JAMA Intern Med. 2026 Apr 1;186(4):416-424. doi: 10.1001/jamainternmed.2025.8008.
PMID: 41697676DERIVEDDrake C, Granados I, Rader A, Brucker A, Hoeffler S, Goldstein BA, Chamorro C, Johnson F, Hinz EM, Bedoya AD, German JC, Hauser J, Thacker C, Spratt SE. Addressing cost barriers to healthy eating with Eat Well, a prescription produce subsidy, for patients with diabetes and at risk for food insecurity: Study protocol for a type 1 hybrid effectiveness-implementation pragmatic randomized controlled trial. Contemp Clin Trials. 2024 Oct;145:107655. doi: 10.1016/j.cct.2024.107655. Epub 2024 Aug 5.
PMID: 39111387DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2023
First Posted
June 9, 2023
Study Start
June 20, 2023
Primary Completion
July 16, 2024
Study Completion
May 1, 2026
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Access to all participant data and information will be restricted to authorized personnel. Internal monitoring of data may occur as required by Duke for investigator-initiated clinical research.